BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 17, 2000
View Archived Issues
Medarex and Eos Biotechnology establish genomics-based antibody drug alliance
Read More
NCI extends two CRADAs with Therion Biologics for cancer vaccines
Read More
Kyowa Hakko and Geron extend telomerase partnership
Read More
Phase III study of ALX1-11 now under way for treatment of osteoporosis
Read More
Novel gene therapy reverses atherosclerotic process in mice
Read More
First clinical trial of MBI-853NL begins
Read More
Campath BLA accepted for filing
Read More
Alexion and Brigham & Women's Hospital to develop novel antiinflammatory antibody
Read More
Matrix provides development update at BIO CEO
Read More
MGI Pharma updates irofulven progress during 1999
Read More
Sankyo discovers new antibacterials produced by Streptomyces
Read More
Novel vitamin D compounds for cancer, bone disorders
Read More
Production, synthesis and activity of new Xenova compounds for immunoinflammatory conditions
Read More
Development of cystic fibrosis therapy advances at SciClone
Read More
Marine sponges found to produce potent caspase inhibitors
Read More
Guanylate cyclase-activating agents in early development at Aventis
Read More
Actelion and Genentech to codevelop tezosentan for the U.S. market
Read More
Patient dosing begins in phase I study of first anti-HCV ribozyme therapy
Read More
Pharmacyclics' texaphyrins now claimed for use in macrophage-mediated conditions
Read More
Ganaxolone produces only modest beneficial effects in cerebral hematoma model
Read More
Novartis files for U.S., European approval of new IBS treatment
Read More
XTL reports on phase I testing of XTL-001 at investor conference
Read More
Acute and subchronic testing in mice indicates limited systemic toxicity for GLG-V-13
Read More
Itraconazole increases saquinavir exposure in HIV-infected patients, similar to ritonavir
Read More
Key development projects on track at Novartis
Read More
PDL to humanize Fujisawa antibody
Read More